September 10, 2026

Two ERC Starting Grants for Scientists at Universität Heidelberg

Two ERC Starting Grants for Scientists at Universität Heidelberg

European Research Council funds groundbreaking projects in paleoclimatology and cancer neuroscience

The European Research Council (ERC) is awarding two valuable grants for early career researchers – two ERC Starting Grants – to Heidelberg University. One of them, worth 1.5 million euros, goes to PD Dr. Sophie Warken, who does her research at the Institutes of Earth Sciences and of Environmental Physics. With the aid of dripstones, she will reconstruct the activity of tropical cyclones in the past to understand the underlying driving processes and to derive foundations for modeling future extreme weather events. The other grantee is Dr. Dr. Varun Venkataramani from the Medical Faculty Heidelberg. The neurologist and neuroscientist studies interactions between the nerve system and cancer, in order to gain new findings on the development of aggressive brain tumors. The ERC is allocating approximately 2.4 million euros for his research project on glioblastomas. The two ERC Starting Grants will be funded for five years.

Tropical cyclones – extreme weather events involving heavy rain, often with fatal consequences – are subject to natural fluctuations which it has so far not been possible to model due to incomplete databases. This is the starting point of Dr. Warken’s ERC project “Trace Metals in Speleothems – Advancing Paleotempestology Using a Novel Geochemical Proxy of Tropical Cyclone Activity” (PaleoTraCeS). In her interdisciplinary research studies in the field of paleoclimatology, the physicist and earth scientist wants to reconstruct the activity of cyclones across several hundred millennia. To do so, Dr. Warken will study the metal sediments in cave dripstones. Called speleothems, they are natural climate archives containing precisely datable information on the environmental events of past glacial and interglacial periods. The research aims to identify climatic factors in the variability of tropical cyclones and to translate them into quantifiable variables to be able to model future extreme weather events. In the long term, the findings from the PaleoTraCeS project are also to contribute to improving the hazard assessment for cyclone-prone world regions. Sophie Warken heads a research group on tropical climate variability and speleothem research based at Heidelberg University’s Institute of Earth Sciences and Institute of Environmental Physics.

Dr. Dr. Venkataramani’s studies are located in the field of cancer neuroscience, which he cofounded. With his team, the neurologist and neuroscientist is primarily involved in the groundbreaking discovery of how healthy nerve cells in the brain make contact with the tumor cells of glioblastomas, thereby fueling the spread of these incurable brain tumors. His latest investigations show that what is called trogocytosis plays an important role here. The tumor cells “nibble” at the nerve cells using their membrane protrusions and consume parts of the neural structures that actually serve to transport information. How the glioblastomas succeed in remodeling the synaptic environment in the brain for their own purposes is the topic of the ERC project Varun Venkataramani is leading on “Brain Tumor Progression via Trogocytosis of the Synaptic Microenvironment” (BITE), which is to be carried out in close cooperation with scientists at the German Cancer Research Center. Within the project, he will examine the molecular mechanisms of trogocytosis. The aim is to map the dynamics of this cellular process across tumor evolution. It should then be possible to determine the optimum point in time for therapeutic interventions. Their purpose would be to impair tumor progression while preserving neuronal connectivity. Varun Venkataramani heads a research group based in the Department of Neurology at Heidelberg University Hospital. With his team, he is part of the European Center for Neuro-Oncology at the Medical Faculty Heidelberg of Heidelberg University.

With the ERC Starting Grant, the European Research Council supports outstanding early-career researchers from all disciplines who have already proved themselves through excellent work and want to implement cutting-edge research projects with ERC funding. The grant amount is generally up to 1.5 million euros. Additional finance can be approved if this is required to carry out the research studies.

Further Information

Our latest News

discover more
Hummingbird Diagnostics Showcases New Data Utilizing Blood-Based Small RNA for Lung Cancer Treatment Monitoring at ESMO Congress 2026

Hummingbird Diagnostics Showcases New Data Utilizing Blood-Based Small RNA for Lung Cancer Treatment Monitoring at ESMO Congress 2026

Study demonstrates the ability of small RNA to inform lung cancer treatment strategies HEIDELBERG, Germany, October 26, 2026 – Hummingbird Diagnostics GmbH, a pioneer in blood-based small RNA biomarker discovery and assay development, today announced new clinical data demonstrating the ability of small RNA to enable adaptive treatment strategies in lung cancer patients. The results […]

Newsletter der BMBH: Biobanking Update!

Newsletter der BMBH: Biobanking Update!

Informationen über unsere Aktivitäten und aktuelle Entwicklungen im Biobanking am Standort und darüber hinaus. IN DIESER AUSGABE__Die BMBH im ÜberblickAktuelles aus der BMBHAktuelles aus denMitgliedsbiobankenNationale / InternationaleBiobanking-AktivitätenPublikationenAnstehende Termine

Huntington’s Disease Biomarkers: Key Molecular Targets and Antibody Tools for HD Research

Huntington’s Disease Biomarkers: Key Molecular Targets and Antibody Tools for HD Research

Proteins to Watch in Huntington’s Disease Research When developing assays to study Huntington’s disease (HD), scientists have a rare advantage: they know the exact genetic cause. But that hasn’t made the biological mechanism any easier to tackle. Despite decades of research, effective treatments remain limited for this progressive degenerative disease.2 HD is inherited in an autosomal-dominant […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp